DexCom
DXCM
$137.87
Share price
2.89%
Change (1 day)
11.34%
Change (1 year)
Categories
P/S ratio for DexCom (DXCM)
P/S ratio as of April 2024 (TTM): 15.1
According to DexCom's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.0733. At the end of 2023 the company had a P/S ratio of 3.33.
P/S ratio history for DexCom from 2007 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.33 | -78.2% |
| 2022 | 15.3 | -28.13% |
| 2021 | 21.3 | 15.35% |
| 2020 | 18.4 | 35.74% |
| 2019 | 13.6 | 29.88% |
| 2018 | 10.5 | 50.57% |
| 2017 | 6.94 | -21.14% |
| 2016 | 8.80 | -47.12% |
| 2015 | 16.6 | 1.39% |
| 2014 | 16.4 | 2.32% |
| 2013 | 16.0 | 69.65% |
| 2012 | 9.46 | 14.76% |
| 2011 | 8.24 | -52.7% |
| 2010 | 17.4 | 39.24% |
| 2009 | 12.5 | 49.55% |
| 2008 | 8.37 | -84.68% |
| 2007 | 54.6 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.85 | -74.47% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.62 | -69.32% | 🇺🇸 USA |
 Medtronic MDT | 3.30 | -78.09% | 🇮🇪 Ireland |
 Becton Dickinson BDX | 3.47 | -77.01% | 🇺🇸 USA |
 Edwards Lifesciences EW | 8.88 | -41.07% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | 3.03 | -79.88% | 🇺🇸 USA |
 QuidelOrtho QDEL | 0.9107 | -93.96% | 🇺🇸 USA |
 West Pharmaceutical WST | 9.57 | -36.49% | 🇺🇸 USA |